Queen's Hospital is a hospital in Romford in the London Borough of Havering. It was built on the site of the former Oldchurch Park, a short distance south of the town centre. It is run by Barking, Havering and Redbridge University Hospitals NHS Trust.

There are 939 beds in Barking, Havering and Redbridge University Hospitals NHS Trust.

During the past decade, Barking, Havering and Redbridge University Hospitals NHS Trust conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 5 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 3 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Barking, Havering and Redbridge University Hospitals NHS Trust" #1 sponsor was "Pfizer" with 3 trials, followed by "University College, London" with 3 trials sponsored, "Imperial College London" with 2 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Barking, Havering and Redbridge University Hospitals NHS Trust" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "University College, London" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Barking, Havering and Redbridge University Hospitals NHS Trust" with 1 trials as a collaborator and "Barts & The London NHS Trust" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "Barking, Havering and Redbridge University Hospitals NHS Trust" are "Psoriatic Arthritis" (2 trials), "Anaplastic Thyroid Cancer" (1 trials), "Antiphospholipid Syndrome" (1 trials), "Arthritis, Psoriatic" (1 trials) and "Brain Ischemia" (1 trials). Many other conditions were trialed in "Barking, Havering and Redbridge University Hospitals NHS Trust" in a lesser frequency.

Most popular intervention types in "Barking, Havering and Redbridge University Hospitals NHS Trust" are "Drug" (9 trials), "Device" (2 trials), "Other" (2 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Obinutuzumab" (2 trials), "Tofacitinib" (2 trials), "AZD5363" (1 trials) and "Adalimumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Barking, Havering and Redbridge University Hospitals NHS Trust" are 14 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Barking, Havering and Redbridge University Hospitals NHS Trust". undefined are not yet recruiting, 5 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Barking, Havering and Redbridge University Hospitals NHS Trust, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Barking, Havering and Redbridge University Hospitals NHS Trust, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".